Key facts
- This page summarizes Peter Donato's Form 4 filing for Zomedica Corp. (ZOMDF).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 15 May 2024, 16:35.
Peter Donato - 13 May 2024 Form 4 Insider Report for Zomedica Corp. (ZOMDF)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ZOMDF
- Reported as of
- 13 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 May 2024, 16:35:29 UTC
- Prior SEC filing
- 20 Mar 2023
- Next SEC filing
- 11 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Peter Donato
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Peter Donato filed Form 4 for Zomedica Corp. (ZOMDF) on 15 May 2024.
Change
- Previous filing in this sequence was filed on 20 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZOM
transaction
Derivative
Options to Buy Common Stock
Award
- Transaction value
- $0
- Shares
- +2,500,000
- Change %
- Price
- $0.000000
- Shares after
- 2,500,000
- Date
- 13 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,500,000
- Exercise price
- $0.1400
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock options vest annually in four equal installments commencing on May 13, 2025.